S Eriksson

No ORCID on file · 1 paper in corpus

nonrandomized-trial 1997

Therapeutic efficacy and bone mineral density response during and following a three-month re-treatment of endometriosis with nafarelin (Synarel)

American journal of obstetrics and gynecology ·doi:10.1016/s0002-9378(97)70084-x

OBJECTIVE: Our goal was to determine the effects of a repeated course of the gonadotropin-releasing hormone agonist nafarelin on symptoms and signs of endometriosis and lumbar and distal radius bone mineral density. STUDY DESIGN: Forty-fiv…